Discover investment opportunities in Best Medical AI Stocks using our Smart AI Filter.
AI is processing your request...
Scanning thousands of stocks to find the best matches...
Discover investment opportunities in Best Medical AI Stocks using our Smart AI Filter.
AI is processing your request...
Scanning thousands of stocks to find the best matches...
Discover investment opportunities in Best Medical AI Stocks using our Smart AI Filter.
10 stocks found for "Best Medical AI Stocks"
Security name | Expected returns | Sharpe Ratio | Beta | Volatility | P/E Ratio | Dividend Yield |
|---|---|---|---|---|---|---|
1.24 Risk measure | ±27.6% Price volatility | 13.6 Valuation | 0.00% Annual yield | |||
1.77 Risk measure | ±71.4% Price volatility | -18.6 Valuation | 0.00% Annual yield | |||
1.92 Risk measure | ±85.0% Price volatility | -11.8 Valuation | 0.00% Annual yield | |||
0.36 Risk measure | ±26.9% Price volatility | 24.5 Valuation | 0.00% Annual yield | |||
1.50 Risk measure | ±64.8% Price volatility | -8.0 Valuation | 0.00% Annual yield | |||
0.92 Risk measure | ±51.9% Price volatility | 41.3 Valuation | 0.00% Annual yield | |||
0.64 Risk measure | ±28.2% Price volatility | 69.3 Valuation | 0.00% Annual yield | |||
0.62 Risk measure | ±33.1% Price volatility | 25.0 Valuation | 0.82% Annual yield | |||
1.19 Risk measure | ±53.7% Price volatility | -156.9 Valuation | 0.00% Annual yield | |||
1.02 Risk measure | ±49.1% Price volatility | 40.9 Valuation | 0.00% Annual yield |
This search uses our Smart AI Filter to identify stocks matching your criteria. Results are ranked by relevance and include key financial metrics to help you make informed investment decisions.
Get personalized stock recommendations, save custom screens, and access premium filters. All our screening tools are free—signing up gives you more personalized results and the ability to save your research.
Compliance disclosure:
The securities listed on this website have not paid to be included in the results. The inclusion of any securities in the results shown does not imply any relationship with PortfolioPilot. The order of the results is ranked based on the Sharpe Ratio, which is a measure of risk-adjusted return. Please note that these listings are not recommendations or financial advice. Past performance is not indicative of future results.
Q: What makes ISRG a strong candidate for investors interested in surgical robotics?
A: Intuitive Surgical, Inc. (ISRG) is a leader in robotic-assisted surgery with its da Vinci systems. The firm's market dominance, innovation-driven growth, and recurring revenue model from instruments and accessories appeal to growth-focused investors.
Q: How does TDOC fit into the telehealth sector?
A: Teladoc Health, Inc. (TDOC) is a prominent player in the telehealth industry, providing virtual healthcare services. Its widespread platform and increasing demand for remote healthcare during the pandemic highlight its potential in this growing sector.
Q: Why is DXCM appealing to investors interested in diabetes management technologies?
A: DexCom, Inc. (DXCM) specializes in continuous glucose monitoring systems, benefiting from the increasing prevalence of diabetes. Its cutting-edge technology and recurring sensor sales make it attractive to investors focusing on healthcare innovation.
Q: What potential does GH offer in the realm of cancer detection?
A: Guardant Health, Inc. (GH) is a leader in liquid biopsy tests for cancer detection. Its innovative diagnostic solutions provide a non-invasive way to detect and manage cancer, appealing to those interested in breakthrough healthcare technology.
Q: How does NVCR stand out in the treatment of aggressive cancers?
A: NovoCure Limited (NVCR) develops Tumor Treating Fields therapy, offering a novel approach to treating aggressive types of cancer. Its unique, less invasive treatment option may attract investors seeking innovative cancer therapies.
Q: In what ways does EXAS contribute to colorectal cancer screening?
A: Exact Sciences Corporation (EXAS) is known for its non-invasive colorectal cancer screening test, Cologuard. Its early detection capabilities and strong market presence in preventative care make it appealing to health-focused investors.
Get a deeper insight into the potential performance of IQVIA (IQV) for the quarter ended June 2025 by going beyond Wall Street's top-and-bottom-line estimates and examining the estimates for some of its key metrics.
Read more